Phase II study of 'dose-dense' high-dose chemotherapy treatment with peripheral-blood progenitor-cell support as primary treatment for patients with advanced ovarian cancer Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Hematopoietic Stem Cell Transplantation
  • Ovarian Neoplasms

abstract

  • The Gynecologic Oncology Group has initiated a pilot phase II trial of this approach in patients with optimally debulked stage III ovarian cancer. There is no evidence to support the use of this or other aggressive regimens outside of a clinical trial.

publication date

  • May 1998

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 9586901

Additional Document Info

start page

  • 1852

end page

  • 60

volume

  • 16

number

  • 5